Zobrazeno 1 - 10
of 3 145
pro vyhledávání: '"cetp"'
Publikováno v:
Lipids in Health and Disease, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background Dysferlin-deficient limb-girdle muscular dystrophy type 2B (Dysf) mice are notorious for their mild phenotype. Raising plasma total cholesterol (CHOL) via apolipoprotein E (ApoE) knockout (KO) drastically exacerbates muscle wastin
Externí odkaz:
https://doaj.org/article/e8659e29265043dda704e01bf0dd7c5c
Autor:
Zhehan Yang, Junpan Chen, Minghao Wen, Jiayuan Lei, Ming Zeng, Sichen Li, Yao Long, Zhiyi Zhou, Chunyan Wang
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundAberrant lipid metabolism is intricately linked to the development of endometrial cancer, and statin lipid-lowering medications are regarded as promising adjunctive therapies for future management of this malignancy. This study employed Men
Externí odkaz:
https://doaj.org/article/ca109bd773904e9281e53cb62cface66
Autor:
Sophie Galier, Maryam Darabi, Feng Ma, Clément Materne, Isabelle Guillas, Wilfried Le Goff, Anatol Kontush, Maryse Guerin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background The capacity of high‐density lipoprotein cholesterol (HDL) to acquire free cholesterol (FC) from triglyceride‐rich lipoproteins during lipoprotein lipase–dependent lipolysis in a process of reverse remnant cholesterol transport, has
Externí odkaz:
https://doaj.org/article/f0a013750bc54352b6131324bd5114af
Autor:
Bohdan B. Khomtchouk, Patrick Sun, Zane A. Maggio, Marc Ditmarsch, John J. P. Kastelein, Michael H. Davidson
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionCholesteryl ester transfer protein (CETP) inhibitors, initially developed for treating hyperlipidemia, have shown promise in reducing the risk of new-onset diabetes during clinical trials. This positions CETP inhibitors as potential candi
Externí odkaz:
https://doaj.org/article/1eb16bfb01c4401cb43562904945fd68
Publikováno v:
Lipids in Health and Disease, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Background It remains controversial whether the long-term use of statins or newer nonstatin drugs has a positive effect on human longevity. Therefore, this study aimed to investigate the genetic associations between different lipid-lowering
Externí odkaz:
https://doaj.org/article/6fcb296427a746899b43b9cf837a65ac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alexia Rouland, Thomas Gautier, Damien Denimal, Laurence Duvillard, Isabelle Simoneau, David Rageot, Bruno Vergès, Benjamin Bouillet
Publikováno v:
Metabolites, Vol 14, Iss 9, p 487 (2024)
ApolipoproteinC1 (apoC1) is the main physiological inhibitor of the cholesterol ester transfer protein (CETP). Increased CETP activity is associated with macrovascular complications in patients with type 1 diabetes (T1D). ApoC1 has lost its ability t
Externí odkaz:
https://doaj.org/article/fb6d1a7fe0674277b327507c272724ef
Autor:
Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha, Maria Dalamaga
Publikováno v:
Metabolites, Vol 14, Iss 7, p 388 (2024)
Atherosclerotic cardiovascular disease poses a significant global health issue, with dyslipidemia standing out as a major risk factor. In recent decades, lipid-lowering therapies have evolved significantly, with statins emerging as the cornerstone tr
Externí odkaz:
https://doaj.org/article/2a340872eb454ae69d4ead37a06e2980
Publikováno v:
Chinese Journal of Population, Resources and Environment, Vol 21, Iss 3, Pp 121-136 (2023)
Based on a panel dataset spanning from 2003 to 2019 and encompassing 284 prefecture-level cities in China, this study treats the implementation of the carbon emissions trading policy (CETP) as a quasi-natural experiment. In addition, it employs a spa
Externí odkaz:
https://doaj.org/article/4e7a4052932042b68ab843d95a182608
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 27, Iss 5, Pp 522-529 (2023)
One of the most common congenital metabolic disorders is familial hypercholesterolemia. Familial hyper-cholesterolemia is a condition caused by a type of genetic defect leading to a decreased rate of removal of low-density lipoproteins from the blood
Externí odkaz:
https://doaj.org/article/ea71e6866cde4052bdb646221d3a7b0b